Targeted mutation of Fas ligand gene attenuates brain inflammation in experimental stroke

Brain, Behavior, and Immunity

Volumn 26, Issue 1, 2012, Pages 61-71

  Niu, Feng nan ^a   Zhang, Xin ^b,c   Hu, Xiao ming ^d   Chen, Jun ^d   Chang, Lei lei ^a,c   Li, Jing wei ^a,c   Liu, Zhuo ^a,c   Cao, Wangsen ^b   Xu, Yun ^a,b,c  

^a THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^c NANJING UNIVERSITY   (China)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

FasL; Inflammation; Neuroprotection; Stroke; T lymphocytes

Indexed keywords

FAS LIGAND; LIPOPOLYSACCHARIDE; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; BRAIN ISCHEMIA; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENCEPHALITIS; GENE MUTATION; INFLAMMATORY CELL; MALE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; MIGRATION INHIBITION; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T CELL DEPLETION; TH1 TH2 BALANCE; WILD TYPE;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BRAIN; BRAIN EDEMA; BRAIN ISCHEMIA; CELL COUNT; CEREBRAL INFARCTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAS LIGAND PROTEIN; FLOW CYTOMETRY; GENE TARGETING; IMMUNOHISTOCHEMISTRY; INFARCTION, MIDDLE CEREBRAL ARTERY; INFLAMMATION; INJECTIONS, INTRAVENTRICULAR; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MUTATION; PROTO-ONCOGENE PROTEINS C-JUN; REAL-TIME POLYMERASE CHAIN REACTION; STROKE;

EID: 81355147548     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2011.07.235     Document Type: Article

References (38)

1. Arumugam T.V., Granger D.N., Mattson M.P. Stroke and T-cells. Neuromol. Med. 2005, 7:229-242.
2. Askenasy N., Yolcu E.S., Yaniv I., Shirwan H. Induction of tolerance using Fas ligand: a double-edged immunomodulator. Blood 2005, 105:1396-1404.
3. Borges V.M., Falcao H., Leite-Junior J.H., Alvim L., Teixeira G.P., Russo M., Nobrega A.F., Lopes M.F., Rocco P.M., Davidson W.F., Linden R., Yagita H., Zin W.A., DosReis G.A. Fas ligand triggers pulmonary silicosis. J. Exp. Med. 2001, 194:155-164.
4. Bright R., Raval A.P., Dembner J.M., Perez-Pinzon M.A., Steinberg G.K., Yenari M.A., Mochly-Rosen D. Protein kinase C delta mediates cerebral reperfusion injury in vivo. J. Neurosci. 2004, 24:6880-6888.
5. Chen J., Li Y., Wang L., Zhang Z., Lu D., Lu M., Chopp M. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001, 32:1005-1011.
6. Chen Z.B., Huang D.Q., Niu F.N., Zhang X., Li E.G., Xu Y. Human urinary kallidinogenase suppresses cerebral inflammation in experimental stroke and downregulates nuclear factor-kappaB. J. Cereb. Blood Flow Metab. 2010, 30:1356-1365.
7. Choi C., Benveniste E.N. Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses. Brain Res. Brain Res. Rev. 2004, 44:65-81.
8. Deng H., Han H.S., Cheng D., Sun G.H., Yenari M.A. Mild hypothermia inhibits inflammation after experimental stroke and brain inflammation. Stroke 2003, 34:2495-2501.
9. Dosreis G.A., Borges V.M., Zin W.A. The central role of Fas-ligand cell signaling in inflammatory lung diseases. J. Cell. Mol. Med. 2004, 8:285-293.
10. Dupont P.J., Warrens A.N. Fas ligand exerts its pro-inflammatory effects via neutrophil recruitment but not activation. Immunology 2007, 120:133-139.
11. Gee J.M., Kalil A., Shea C., Becker K.J. Lymphocytes: potential mediators of postischemic injury and neuroprotection. Stroke 2007, 38:783-788.
12. Jack C.S., Arbour N., Manusow J., Montgrain V., Blain M., McCrea E., Shapiro A., Antel J.P. TLR signaling tailors innate immune responses in human microglia and astrocytes. J. Immunol. 2005, 175:4320-4330.
13. Kaminska B., Gozdz A., Zawadzka M., Ellert-Miklaszewska A., Lipko M. MAPK signal transduction underlying brain inflammation and gliosis as therapeutic target. Anat. Rec. (Hoboken) 2009, 292:1902-1913.
14. Kaur G., Han S.J., Yang I., Crane C. Microglia and central nervous system immunity. Neurosurg. Clin. N. Am. 2010, 21:43-51.
15. Kerschensteiner M., Meinl E., Hohlfeld R. Neuro-immune crosstalk in CNS diseases. Neuroscience 2009, 158:1122-1132.
16. Kunes P., Krejsek J., Brtko M., Mandak J., Kolackova M., Trojackova Kudlova M., Andrys C. Neutrophil apoptosis by Fas/FasL: harmful or advantageous in cardiac surgery?. Thorac. Cardiovasc. Surg. 2009, 57:1-6.
17. Lettau M., Paulsen M., Kabelitz D., Janssen O. FasL expression and reverse signalling. Results Probl. Cell Differ. 2009, 49:49-61.
18. Liu L., Kim J.Y., Koike M.A., Yoon Y.J., Tang X.N., Ma H., Lee H., Steinberg G.K., Lee J.E., Yenari M.A. FasL shedding is reduced by hypothermia in experimental stroke. J. Neurochem. 2008, 106:541-550.
19. Luo H.R., Loison F. Constitutive neutrophil apoptosis: mechanisms and regulation. Am. J. Hematol. 2008, 83:288-295.
20. Martin-Villalba A., Hahne M., Kleber S., Vogel J., Falk W., Schenkel J., Krammer P.H. Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke. Cell Death Differ. 2001, 8:679-686.
21. Matsumoto N., Imamura R., Suda T. Caspase-8- and JNK-dependent AP-1 activation is required for Fas ligand-induced IL-8 production. FEBS J. 2007, 274:2376-2384.
22. Milatovic D., Zaja-Milatovic S., Montine K.S., Horner P.J., Montine T.J. Pharmacologic suppression of neuronal oxidative damage and dendritic degeneration following direct activation of glial innate immunity in mouse cerebrum. J. Neurochem. 2003, 87:1518-1526.
23. Offner H., Subramanian S., Parker S.M., Afentoulis M.E., Vandenbark A.A., Hurn P.D. Experimental stroke induces massive, rapid activation of the peripheral immune system. J. Cereb. Blood Flow Metab. 2006, 26:654-665.
24. Rosenbaum D.M., Gupta G., D'Amore J., Singh M., Weidenheim K., Zhang H., Kessler J.A. Fas (CD95/APO-1) plays a role in the pathophysiology of focal cerebral ischemia. J. Neurosci. Res. 2000, 61:686-692.
25. Sairanen T., Karjalainen-Lindsberg M.L., Paetau A., Ijas P., Lindsberg P.J. Apoptosis dominant in the periinfarct area of human ischaemic stroke-a possible target of antiapoptotic treatments. Brain 2006, 129:189-199.
26. Seko Y., Kayagaki N., Seino K., Yagita H., Okumura K., Nagai R. Role of Fas/FasL pathway in the activation of infiltrating cells in murine acute myocarditis caused by Coxsackievirus B3. J. Am. Coll. Cardiol. 2002, 39:1399-1403.
27. Song J.H., Bellail A., Tse M.C., Yong V.W., Hao C. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. J. Neurosci. 2006, 26:3299-3308.
28. Sun M., Ames K.T., Suzuki I., Fink P.J. The cytoplasmic domain of Fas ligand costimulates TCR signals. J. Immunol. 2006, 177:1481-1491.
29. Sun M., Fink P.J. A new class of reverse signaling costimulators belongs to the TNF family. J. Immunol. 2007, 179:4307-4312.
30. Suzuki I., Martin S., Boursalian T.E., Beers C., Fink P.J. Fas ligand costimulates the in vivo proliferation of CD8+ T cells. J. Immunol. 2000, 165:5537-5543.
31. Takahashi T., Tanaka M., Brannan C.I., Jenkins N.A., Copeland N.G., Suda T., Nagata S. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994, 76:969-976.
32. Tian L., Rauvala H., Gahmberg C.G. Neuronal regulation of immune responses in the central nervous system. Trends Immunol. 2009, 30:91-99.
33. Wagner D.C., Riegelsberger U.M., Michalk S., Hartig W., Kranz A., Boltze J. Cleaved caspase-3 expression after experimental stroke exhibits different phenotypes and is predominantly non-apoptotic. Brain Res 2011, 1381:237-242.
34. Wang Q., Tang X.N., Yenari M.A. The inflammatory response in stroke. J. Neuroimmunol. 2007, 184:53-68.
35. Worthmann H., Tryc A.B., Goldbecker A., Ma Y.T., Tountopoulou A., Hahn A., Dengler R., Lichtinghagen R., Weissenborn K. The temporal profile of inflammatory markers and mediators in blood after acute ischemic stroke differs depending on stroke outcome. Cerebrovasc. Dis. 2010, 30:85-92.
36. Xu Y., Zhang W., Klaus J., Young J., Koerner I., Sheldahl L.C., Hurn P.D., Martinez-Murillo F., Alkayed N.J. Role of cocaine- and amphetamine-regulated transcript in estradiol-mediated neuroprotection. Proc. Natl. Acad. Sci. USA 2006, 103:14489-14494.
37. Yilmaz G., Granger D.N. Leukocyte recruitment and ischemic brain injury. Neuromolecular. Med. 2010, 12:193-204.
38. Yin W., Signore A.P., Iwai M., Cao G., Gao Y., Johnnides M.J., Hickey R.W., Chen J. Preconditioning suppresses inflammation in neonatal hypoxic ischemia via Akt activation. Stroke 2007, 38:1017-1024.